Brugnera Nunes de Mattos, A.; Maria Cerneski, M.; Reichert, S.; Nava Jaeger, C. Use of Adalimumab, a TNF-Alpha Inhibitor, Is Associated With Paradoxical Psoriasis: Two Clinical Case Reports. Braz J Case Rep. 2023, 3, 12-15.